Navigation Links
FluoroPharma Inc. Expands Technology Platform to Include Agents for Alzheimer's Disease (AD)
Date:3/26/2008

BOSTON, March 26 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced that it has entered into a licensing agreement with Massachusetts General Hospital (MGH) for the development and commercialization of agents for diagnosis and treatment of Alzheimer's disease (AD). The licensed technologies, which were co-developed by FluoroPharma and MGH scientists, target multiple biological processes associated with AD. Currently, there is no single diagnostic test that proves a person has AD. Development of new options for early detection and treatment of Alzheimer's has the potential to improve patient care and create new paths for AD management for the more than 5M Americans that suffer from dementia and other cognitive deficits as a result of AD.

"Our molecular imaging approach to AD includes multiple molecular compositions that target AD associated phenomena -- low acetylcholine and amyloid plaque formation. With some agents, it may be possible to improve brain function by inhibiting the breakdown of acetylcholine, and with others we may be able to prevent the formation of amyloid plaque by inhibiting protein misfolding. As PET imaging tracers, these agents also have potential applications in both diagnosis of the disease and monitoring of the therapy, by differentially accumulating in regions of the brain affected by the disease compared to normal brain tissue," explained Dr. David Elmaleh, FluoroPharma's Chairman and Scientific Founder.

"The technology has the potential to be highly effective due to the agents' enhanced accumulation in the brain," said Dr. Kundakovic, FluoroPharma's President. "As PET imaging agents, these compounds may provide valuable information in patients where early diagnostic and therapeutic information is likely to have the greatest benefit."

About FluoroPharma

FluoroPharma is a molecular imaging company engaged
'/>"/>

SOURCE FluoroPharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Honeywell Expands Aclar(R) Production for Pharmaceutical Industry
2. Murad Expands International Presence With Appointment of Danny Guez
3. Sigma-Aldrich Amends Credit Facility and Expands Commercial Paper Program
4. VIE Healthcare Expands Its Operations in the Midwest, and Obtains First Local Client
5. Eating Disorders Program at Lucile Packard Childrens Hospital Expands to Include Young Adults
6. Dollar Thrifty Automotive Group Expands Mobile Managed Services Contract with InfoLogix
7. Life Spine Expands Home Office Space, More Than Doubling Space Occupied
8. Millennium Expands IBD Franchise with Addition of New Development Candidate
9. inVentiv Clinical Expands Operations to Emerging Latin American Region
10. Anti-Aging/Genetic Health Leader Suracell, Inc. Expands Internationally
11. AlphaDetail, Inc. Expands Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... CA (PRWEB) May 22, 2015 The ... two exciting events in June. They will hold a ... Doctorate and a two-day class on Classical Chinese Medicine. ... June 3, Dr. Steve Given, the Dean of Clinical ... discuss the new First Professional Doctorate program. ACTCM is ...
(Date:5/22/2015)... Utah (PRWEB) May 22, 2015 Mountain Point ... host a ribbon cutting ceremony on Friday, May 29, 2015 ... p.m. to 6 p.m. The new medical center, set to ... North Triumph Boulevard, Lehi, UT 84043. , “The opening ... our team and the Utah County community,” said Kent Loosle, ...
(Date:5/22/2015)... River Valley Health Partners (RVHP) Board ... system’s Chief Financial Officer (CFO), will be leaving the ... the company CFO since 2011. , The Board of ... health system as CFO. Wesley will oversee the health ... Board of Trustees conducts a formal search for a ...
(Date:5/22/2015)... York, New York (PRWEB) May 22, 2015 ... http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who ... due to its use continue to move forward ... Louisiana. According to a Pretrial Order dated May ... the preservation of documents and electronically stored information. ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health ... health brand Nature’s Way, Marc St-Onge has affirmed his ... Skin is an integral part of the agreement with ... to further develop Ascenta Skin into a leading player ... a breakthrough, anti-aging skincare supplement featuring 6 active ingredients ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming June Events 2Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Ascenta Skin President Announces Plans to Grow Brand 2
... each year due to the failure to prevent blood clots ... experts in this weeks BMJ. ,Their warning follows ... by the National Institute for Health and Clinical Excellence (NICE), ... ,It is estimated that VTE kills around 60,000 people every ...
... gives rise to mental health disorders. Not many seem to ... our own backyard. ,Yes it is happening in ... Psychiatric Hospital in capital Srinagar reveals that from a mere ... soared up to 60,000 in the year 2006 alone. ...
... in the Lancet, say that taking aspirin during pregnancy ... pre-eclampsia. ,Scientists who analyzed the results ... evidence pointing to the protective effect of this drug ... blood pressure, affects between 5% and 8% of pregnancies ...
... Park midwifery practice and a Bethesda birth center have ... Washington area women who say they are worried ... outside a hospital or with a midwife's help. ... practices, many citing rising malpractice insurance premiums and lagging ...
... the development of fully human antibodies specific to Plasmodium ... according to a report. The researchers developed these novel ... adults. ,While it remains unclear if in ... due to the lack of suitable animal models, according ...
... Yong, today said the AMA is heartened that a new ... a ban on junk food advertising during childrens television viewing ... advertising foods high in fat, sugar and salt directly to ... Federal Election year, we will continue to call on the ...
Cached Medicine News:Health News:25,000 Needless Deaths Each Year Due to Failure to Tackle Blood Clots in Hospital 2Health News:Strife in Kashmir Drives Thousands to Psychiatric Wards 2Health News:Research Favors Aspirin In Prevention Of Pre-Eclampsia 2Health News:Natural-Birth Centers In U.S Pulling Down The Shutters 2Health News:Natural-Birth Centers In U.S Pulling Down The Shutters 3
(Date:5/22/2015)... , May 22 2015 /CNW/ - The Taskforce representing ... very appreciative of all the hard work that the Minister ... past six months. This program recognizes the needs of the ... at least $75,000 a year, tax free, with annual adjustments ... be eligible for annual payments of $100,000 based on the ...
(Date:5/22/2015)... Calif. , May 22, 2015 /PRNewswire/ ... the Company has commenced termination of its ... brodalumab with AstraZeneca (LON:AZN, STO:AZN and NYSE: ... inhibitor, is in development for patients with ... spondyloarthritis.  The decision was based on events ...
(Date:5/22/2015)... mayo de 2015 Dipexium Pharmaceuticals, ... farmacéutica de fase tardía centrada en el ... 0.8%), y colaboradores de investigación clínica, han ... el diseño innovador de los ensayos pivotales ... evalúan Locilex®, su nuevo péptido de antibiótico ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6
Medpor 2/3 Orbit implants are designed to replace non load bearing bony structures in the orbital area....
... Orbital Rim implant can provide up to ... to be trimmed to meet the needs ... allows it to rest on the most ... flange allows easier positioning of the implant ...
Flattened points in vertical plane, straight shafts, cross action, round handle....
1.5 mm inner cutting edge....
Medicine Products: